Natco Pharma Ltd.
|
Balance Sheet
|
|
You can view the
Balance Sheet
for the last 5 years.
Market Cap. (Rs.)
|
18521.75 Cr.
|
P/BV
|
3.80
|
Book Value (Rs.)
|
272.07
|
52 Week High/Low (Rs.)
|
1108/585
|
FV/ML
|
2/1
|
P/E(X)
|
25.89
|
Bookclosure
|
26/02/2024
|
EPS (Rs.)
|
39.94
|
Div Yield (%)
|
0.53
|
|
(Rs. in Crs.)
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
No. of Equity Shares (in Lacs) | 1825.20 | 1825.20 | 1823.38 | 1820.68 | 1827.46 |
| | | | | |
EQUITIES AND LIABILITIES | | | | | |
SHAREHOLDER'S FUNDS | | | | | |
Equity Share Capital | 36.50 | 36.50 | 36.50 | 36.40 | 36.50 |
Total Share Capital | 36.50 | 36.50 | 36.50 | 36.40 | 36.50 |
| | | | | |
Reserves and Surplus | 4837.30 | 4223.70 | 4067.60 | 3737.10 | 3452.50 |
Total Reserves and Surplus | 4837.30 | 4223.70 | 4067.60 | 3737.10 | 3452.50 |
Employees Stock Options | 0.00 | 3.40 | 17.50 | 0.00 | 0.00 |
Total Shareholders Funds | 4873.80 | 4263.60 | 4121.60 | 3773.50 | 3489.00 |
Minority Interest | 0.00 | 0.00 | 1.80 | 11.20 | 2.00 |
| | | | | |
NON-CURRENT LIABILITIES | | | | | |
Long Term Borrowings | 0.00 | 0.00 | 0.00 | 0.90 | 0.00 |
Deferred Tax Liabilities [Net] | 12.40 | 30.10 | 41.30 | 25.90 | 11.60 |
Other Long Term Liabilities | 2.80 | 9.30 | 2.00 | 0.80 | 0.80 |
Long Term Provisions | 85.30 | 95.70 | 99.60 | 90.20 | 71.00 |
Total Non-Current Liabilities | 100.50 | 135.10 | 142.90 | 117.80 | 83.40 |
| | | | | |
CURRENT LIABILITIES | | | | | |
Short Term Borrowings | 165.00 | 404.00 | 265.80 | 315.00 | 386.30 |
Trade Payables | 263.80 | 161.80 | 146.20 | 255.40 | 217.00 |
Other Current Liabilities | 237.40 | 127.60 | 100.80 | 104.40 | 116.40 |
Short Term Provisions | 16.90 | 17.00 | 12.80 | 10.50 | 9.00 |
Total Current Liabilities | 683.10 | 710.40 | 525.60 | 685.30 | 728.70 |
| | | | | |
Total Capital And Liabilities | 5657.40 | 5109.10 | 4791.90 | 4587.80 | 4303.10 |
| | | | | |
ASSETS | | | | | |
NON-CURRENT ASSETS | | | | | |
Tangible Assets | 2239.10 | 2178.90 | 2013.80 | 1575.60 | 1218.50 |
Intangible Assets | 132.60 | 82.20 | 9.40 | 8.80 | 8.70 |
Capital Work-In-Progress | 64.30 | 129.50 | 223.40 | 518.00 | 637.60 |
Fixed Assets | 2436.00 | 2390.60 | 2246.60 | 2102.40 | 1864.80 |
Goodwill On Consolidation | 55.20 | 50.70 | 0.00 | 0.00 | 0.00 |
Non-Current Investments | 87.30 | 104.40 | 159.40 | 83.60 | 19.90 |
Long Term Loans And Advances | 0.00 | 0.00 | 15.80 | 16.10 | 2.00 |
Other Non-Current Assets | 78.60 | 66.20 | 32.80 | 60.10 | 69.20 |
Total Non-Current Assets | 2657.10 | 2611.90 | 2454.60 | 2262.20 | 1955.90 |
| | | | | |
| | | | | |
CURRENT ASSETS | | | | | |
Current Investments | 305.00 | 203.70 | 144.30 | 28.70 | 148.70 |
Inventories | 742.90 | 762.00 | 798.20 | 558.00 | 529.00 |
Trade Receivables | 856.10 | 620.60 | 412.90 | 551.30 | 506.20 |
Cash And Cash Equivalents | 546.30 | 206.10 | 283.50 | 66.00 | 279.50 |
Short Term Loans And Advances | 10.20 | 10.40 | 13.10 | 8.40 | 7.10 |
OtherCurrentAssets | 539.80 | 694.40 | 685.30 | 1113.20 | 876.70 |
Total Current Assets | 3000.30 | 2497.20 | 2337.30 | 2325.60 | 2347.20 |
| | | | | |
Total Assets | 5657.40 | 5109.10 | 4791.90 | 4587.80 | 4303.10 |
| | | | | |
OTHER INFORMATION | | | | | |
| | | | | |
CONTINGENT LIABILITIES, COMMITMENTS | | | | | |
Contingent Liabilities | 22.10 | 22.40 | 28.00 | 98.80 | 78.10 |
| | | | | |
BONUS DETAILS | | | | | |
Bonus Equity Share Capital | 5.73 | 5.73 | 5.73 | 5.73 | 5.74 |
| | | | | |
NON-CURRENT INVESTMENTS | | | | | |
Non-Current Investments Quoted Market Value | 0.00 | 39.90 | 71.20 | 51.20 | 0.00 |
Non-Current Investments Unquoted Book Value | 87.30 | 64.20 | 89.00 | 33.50 | 19.90 |
| | | | | |
CURRENT INVESTMENTS | | | | | |
Current Investments Quoted Market Value | 98.90 | 81.20 | 15.60 | 5.00 | 6.80 |
Current Investments Unquoted Book Value | 204.40 | 122.10 | 128.70 | 23.70 | 141.90 |